Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Toll-like receptor 2/4 ligands

AIDS

Volumn 24, Issue 12, 2010, Pages 1841-1848

  Mureith, Marianne W ^a,b   Chang, J Judy ^b   Lifson, Jeffrey D ^c   Ndung'U, Thumbi ^a   Altfeld, Marcus ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

HIV 1; Lipopolysaccharide; Microbial translocation; Monocytes; Toll like receptors

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING;

CELL LINE; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MALE; MONOCYTES; RNA, VIRAL; TOLL-LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 77954759074     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833ad89a     Document Type: Article

References (28)

1. Deeks SG, Walker BD. The immune response to AIDS virus infection: good, bad, or both? J Clin Invest 2004; 113:808-810.
2. Giorgi JV, Fahey JL, Smith DC, Hultin LE, Cheng HL, Mitsuyasu RT, Detels R. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987; 138:3725-3730.
3. Fahey JL, Taylor JM, Manna B, Nishanian P, Aziz N, Giorgi JV, Detels R. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 1998; 12:1581-1590.
4. Chang JJ, Altfeld M. TLR-mediated immune activation in HIV. Blood 2009; 113:269-270.
5. Douek D. HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med 2007; 15:114-117.
6. Haynes BF. Gut microbes out of control in HIV infection. Nat Med 2006; 12:1351-1352.
7. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003; 85:85-95.
8. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16:3-9.
9. Bekeredjian-Ding I, Roth SI, Gilles S, Giese T, Ablasser A, Hornung V, et al. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. J Immunol 2006; 176:7438-7446.
10. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17:1-14.
11. AkamineM, Higa F,Arakaki N, KawakamiK, Takeda K, Akira S, Saito A. Differential roles of Toll-like receptors 2 and 4 in in vitro responses of macrophages to Legionella pneumophila. Infect Immun 2005; 73:352-361.
12. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-2088.
13. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004; 303:1526-1529.
14. Meier A, Alter G, Frahm N, Sidhu H, Li B, Bagchi A, et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007; 81:8180-8191.
15. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, et al. 5-Triphosphate RNA is the ligand for RIG-I. Science 2006; 314:994-997.
16. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
17. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, et al. Endocytosis of HIV-1 activates plasmacy-toid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005; 115:3265-3275.
18. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009; 15:955-959.
19. Bagchi A, Herrup EA, Warren HS, Trigilio J, Shin HS, Valentine C, Hellman J. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol 2007; 178:1164-1171.
20. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergisti-cally trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005; 6:769-776.
21. Sato S, Nomura F, Kawai T, Takeuchi O, Muhlradt PF, Takeda K, Akira S. Synergy and cross-tolerance between Toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J Immunol 2000; 165:7096-7101.
22. Lester RT, Yao X-D, Blake BT, McKinnon LR, Kaul R, Wachihi C, et al. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 2008; 22:685-694.
23. Gorden KB, Gorski KS, Gibson S, Kedl R, Kieper W, Qiu X, et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005; 174:1259-1269.
24. Lee PI, Ciccone EJ, Read SW, Asher A, Pitts R, Douek DC, et al. Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. J Infect Dis 2009; 199:1664-1670.
25. Giorgi JV, Landay A. HIV infection: diagnosis and disease progression evaluation. Methods Cell Biol 1994; 42 (Pt B): 437-455.
26. Gray CM, Schapiro JM, Winters MA, Merigan TC. Changes in CD4R and CD8R T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. AIDS Res Hum Retro-viruses 1998; 14:561-569.
27. Lempicki RA, Kovacs JA, Baseler MW, Adelsberger JW, Dewar RL, Natarajan V, et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4R and CD8R T cell turnover in HIV-infected patients. Proc Natl Acad Sci USA 2000; 97:13778-13783.
28. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, et al. CD4R T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759.